Health & Medicine - Page 5 of 10

The International Society of Amyloidosis (ISA) will be hosting a meeting in Athens from 25 to 26 September 2023 (at the Athenaeum Intercontinental) that will bring together basic scientists and clinical experts from Europe, the United States, South America, Asia, and Australia.

Distinctions Health & Medicine University Community

ShareFacebook TwitterLinkedinTelegramEmailClipboard

Professor Dina Tiniakos, Medical School, National and Kapodistrian University of Athens was appointed as Chair του Advisory Board, European Society of Pathology

Professor Dina Tiniakos, Professor of Pathology and Director, Department of Pathology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens was appointed as Chair of the Advisory Board, European Society of Pathology (ESP) following the unanimous decision of the General Assembly…

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

BE-SAFE Research Project: Development of best practices to reduce the use of sleeping pills

The EU project ‘HORIZON-HLTH-2021-CARE-05-01: Enhancing Quality of Care and Patient Safety’ (BE-SAFE) officially launched on 14 September 2022 involves five Member States of the European Union (Belgium, Germany, Greece, Spain, and Poland), as well as Switzerland and Norway. The inaugural meeting took…

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

The eminent Professor, Dr Betty R. Ferrell, was awarded the title of doctor honoris causa of the NKUA’s Department of Nursing

Dr Betty R. Ferrell, Director of Nursing Research and Education and Professor at City of Hope Medical Center in Duarte, California, USA, was awarded the title of doctor honoris causa of the Department of Nursing of the NKUA’s School of Health Sciences…

Announcements Health & Medicine Science & Technology

ShareFacebook TwitterLinkedinTelegramEmailClipboard

New online course by the National and Kapodistrian University of Athens and the National Evaluation Center of Quality & Technology in Health S.A. 🗓

The 2nd cycle of the distance learning program “Medical Devices: regulatory requirements, assessment, certification, CE marking” starts on October 18, 2023.

Events Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

10th Aegean Hematology Oncology Symposium [14-17/9/23] 🗓

The 10th Aegean Hematology Oncology Symposium will be held on 14-17 September 2023 in Istanbul, Türkiye. The Symposium is categorized and organized as International Congress under the auspices of the Balkan Myeloma Study Group. It is co-organized by the National and Kapodistrian…

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

Long-Term Outcomes With Zanubrutinib vs Ibrutinib in Symptomatic Waldenström’s Macroglobulinemia

Details of the final analysis of the phase III ASPEN trial, which compared zanubrutinib and ibrutinib in symptomatic patients with Waldenström’s macroglobulinemia, were published in the Journal of Clinical Oncology by Meletios A. Dimopoulos, MD, and colleagues.

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

MD Anderson ranked #1 in the nation for cancer care

The University of Texas MD Anderson Cancer Center today was named number one in the nation for cancer care in U.S. News & World Report’s 2023-24 “Best Hospitals” survey. The institution has been one of the nation’s top two hospitals for cancer care since the survey’s…

national cancer institute NFvdKIhxYlU unsplash(2)

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

We are proud to have another publication in WM: “Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study,” (Journal of Clinical Oncology, 21/7/2023)

Announcements Health & Medicine

ShareFacebook TwitterLinkedinTelegramEmailClipboard

FDA approves first over-the-counter birth control pill in U.S. – The Washington Post

Federal regulators Thursday approved the first over-the-counter birth control pill available in the United States, a milestone in decades-long efforts to make oral contraceptives easier to obtain, especially by teenagers and women who don’t regularly see a doctor.